SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001048477-24-000004
Filing Date
2024-01-23
Accepted
2024-01-23 19:47:11
Documents
3
Period of Report
2024-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1706057221.html 4  
1 FORM 4 wk-form4_1706057221.xml 4 3009
2 EX-24 section16filingspowerofa.htm EX-24 3888
3 section16filingspowerofa001.jpg GRAPHIC 219496
  Complete submission text file 0001048477-24-000004.txt   310731
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025
Business Address
MEIER RICHARD A (Reporting) CIK: 0001227305 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 24553942